QUANTITATIVE ANALYSIS OF DRUGS WITH HIGHLY DIFFERENT CONCENTRATIONS OF PHARMACEUTICAL COMPONENTS USING SPECTRAL SUBTRACTION TECHNIQUES
Abstract
References
1. L. Merker, H. U. Haring, A. V. Christiansen, F. Roux, A. Salsali, G. Kim, T. Meinicke, H. J. Woerle, U. C. Broedl, Diabet. Med., 32, 1555-1567 (2015).
2. B. M. Ayoub, RSC Adv., 5, 95703-95709 (2015).
3. B. M. Ayoub, Spectrochim. Acta: Mol. Biomol. Spectrosc., 168, 118-122 (2016).
4. B. M. Ayoub, Der Pharma Chem., 8, 23-29 (2016).
5. Y. M. Fayez, Spectrochim. Acta: Mol. Biomol. Spectrosc., 132, 446-451 (2014).
6. Note for guidance on validation of analytical procedures: Methodology (ICH harmonized tripartite guideline Q2B), Pharm. Ind., 59, 107-110 (1997).
Review
For citations:
Ayoub B.M. QUANTITATIVE ANALYSIS OF DRUGS WITH HIGHLY DIFFERENT CONCENTRATIONS OF PHARMACEUTICAL COMPONENTS USING SPECTRAL SUBTRACTION TECHNIQUES. Zhurnal Prikladnoii Spektroskopii. 2017;84(5):830-833. (In Russ.)